LIUZZI, Grazia Maria
 Distribuzione geografica
Continente #
NA - Nord America 7.303
AS - Asia 3.168
EU - Europa 2.302
SA - Sud America 763
AF - Africa 220
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.765
Nazione #
US - Stati Uniti d'America 7.200
SG - Singapore 1.312
CN - Cina 808
BR - Brasile 627
HK - Hong Kong 417
IT - Italia 388
SE - Svezia 388
DE - Germania 282
RU - Federazione Russa 258
FR - Francia 251
UA - Ucraina 250
FI - Finlandia 194
VN - Vietnam 167
GB - Regno Unito 120
CI - Costa d'Avorio 118
IN - India 118
BD - Bangladesh 57
CA - Canada 53
AR - Argentina 46
IQ - Iraq 43
TR - Turchia 38
ZA - Sudafrica 33
PK - Pakistan 31
BE - Belgio 28
CO - Colombia 25
NL - Olanda 25
MX - Messico 24
VE - Venezuela 22
ID - Indonesia 21
IE - Irlanda 21
PH - Filippine 21
PL - Polonia 21
MA - Marocco 19
JP - Giappone 18
ES - Italia 16
SA - Arabia Saudita 13
UZ - Uzbekistan 13
AT - Austria 12
CL - Cile 11
EC - Ecuador 11
IR - Iran 11
TN - Tunisia 10
ET - Etiopia 9
JO - Giordania 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
OM - Oman 8
AU - Australia 7
LT - Lituania 7
PY - Paraguay 7
EG - Egitto 6
HN - Honduras 6
PS - Palestinian Territory 6
SN - Senegal 6
AZ - Azerbaigian 5
CR - Costa Rica 5
KE - Kenya 5
PE - Perù 5
BO - Bolivia 4
JM - Giamaica 4
KR - Corea 4
LB - Libano 4
PT - Portogallo 4
RS - Serbia 4
UY - Uruguay 4
AL - Albania 3
BH - Bahrain 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 13.754
Città #
Woodbridge 672
Singapore 647
Ashburn 641
Fairfield 605
Chandler 604
Jacksonville 563
San Jose 452
Hong Kong 413
Houston 412
Ann Arbor 333
Nyköping 315
Wilmington 245
Seattle 242
Cambridge 227
Beijing 219
Lawrence 127
Roxbury 126
Abidjan 118
Lauterbourg 117
Nanjing 110
New York 104
Bari 100
Marseille 99
Boardman 85
Des Moines 79
Los Angeles 70
Ho Chi Minh City 58
Inglewood 56
Dallas 55
São Paulo 53
Helsinki 45
Munich 43
Santa Clara 41
Princeton 39
Jiaxing 37
Brooklyn 36
Hanoi 35
Falkenstein 34
Shenyang 34
Buffalo 31
Nanchang 29
Turku 28
Moscow 27
San Diego 27
Brussels 26
Changsha 25
Guangzhou 25
London 25
Hebei 24
Baghdad 22
Chicago 22
Council Bluffs 22
Dublin 21
Shanghai 21
Belo Horizonte 19
Denver 19
Dhaka 19
Rio de Janeiro 19
Amsterdam 17
Frankfurt am Main 17
San Francisco 17
Tianjin 17
Toronto 17
Warsaw 17
Chennai 16
Leawood 16
Leverano 16
Da Nang 15
Dearborn 15
Orem 15
Rome 15
Spongano 15
Tokyo 15
Curitiba 14
Milan 14
Wuhan 14
Auburn Hills 13
Jakarta 13
Montreal 13
Paris 13
Johannesburg 12
Lahore 12
Monmouth Junction 12
Pune 12
Tashkent 12
Caracas 11
Falls Church 11
Mumbai 11
Nuremberg 11
Atlanta 10
Augusta 10
Campinas 10
New Delhi 10
Porto Alegre 10
Salvador 10
Amman 9
Grottaglie 9
Norwalk 9
Stockholm 9
Zhengzhou 9
Totale 9.285
Nome #
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 186
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 181
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 179
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 170
FAD synthesis and degradation in the nucleus create a local flavin cofactor pool 166
A thermodynamic and structural study of myelin basic protein in lipid membrane models 151
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 148
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 146
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 145
Biological variations in a long-term ex situ cultivation: a Mediterranean demosponge as model system 142
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains 140
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 140
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 136
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 136
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 135
Autoimmune Myelofibrosis: report of three cases and review of the literature 131
Aquaporin-4-containing astrocytes sustain a temperature- and mercury-insensitive swelling in vitro 131
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 129
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 128
Native Myelin Proteins and Myelin Assembly in the Central Nervous System 127
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 126
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis 125
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies 124
Anti-endothelial cell antibodies (AECA) in a patient wiyh Takayasu’s arteritis. In: Pathogenesis and immunotherapy of autoimmune diseases. Final program and abstract book 124
Identification of water-soluble proteases in myelin preparations 120
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 120
Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases 119
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex 119
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 119
Recombinant arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 118
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 117
T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors 115
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 115
Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation 114
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 112
New Diagnostic and Therapeutic Options for the Treatment of Multiple Sclerosis 111
Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain 111
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. 110
Crystals of P2 myelin protein in lipid-bound form 109
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 109
Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms 108
Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex 106
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. 105
Purification of bovine P2 myelin protein with bound lipids 105
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 103
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 103
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction 102
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 101
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 101
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 100
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 100
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes 99
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 99
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 98
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 98
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 97
Autoimmune bone marrow fibrosis: a distinct clinicopathological entity 97
The different forms of PNS myelin P0 protein within and outside lipid rafts 96
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 96
Aumento dell’attività della Gelatinasi B nel liquor di pazienti HIV-positivi con malattie neurologiche del Sistema Nervoso Centrale 95
Meccanismo molecolare di “Swelling” in astrociti in coltura 95
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 95
Meccanismi di demielinizzazione in pazienti con neuroAIDS 94
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 94
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 94
Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE/BChE selectivity switch and drug-like characterization 93
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study 93
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 93
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 92
Detection of serum levels and intrathecal synthesis of matrix metallo proteinase-9 in relapsing-remitting multiple sclerosis 91
null 91
null 90
CEREBROSPINAL FLUID MARKERS FOR THE MONITORING OF AIDS DEMENTIA COMPLEX SEVERITY: USEFULNESS OF ANTI-MYELIN BASIC PROTEIN ANTIBODY DETECTION 89
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form 89
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 89
Ruolo delle proteasi nell’induzione e nella patogenesi della sclerosi multipla 88
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 87
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 87
Increased Gelatinase B Activity in the CSF of Patients with HIV-Associated Neurological Diseases 87
null 87
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis 87
Determinazione degli Anticorpi Liquorali Anti-MBP per la Diagnosi di Danno Mielinico in Pazienti con AIDS Dementia Complex 86
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 86
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 85
Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity 84
CNS Myelin Proteins in Lipid-Bound Native Form as Tools for Study, Detection and Treatment of Multiple Sclerosis 83
Demyelination and cerebral toxoplasmosis in HIV-infected patients 82
Intrathecal synthesis of matrix metalloproteinase (MMP)-9 in patients with relapsing-remitting (RR) multiple sclerosis (MS) 82
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 82
Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice 82
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 81
Matrix Metalloproteinases in CNS Inflammation. 81
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 81
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 81
Il ruolo delle proteasi nell’induzione e nella patogenesi della Sclerosi Multipla 81
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 79
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 79
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 79
Follow-up of myelin damage in HIV-associated cryptococcal meningitis. First evidence of anti-myelin basic protein antibodies in the cerebrospinal fluid 78
Plant Lectins Regulate the Release of Matrix Metalloproteases in Rat Glial Cell Cultures 78
Totale 10.748
Categoria #
all - tutte 53.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 154 121 36
2021/2022805 24 116 6 24 33 51 32 47 57 55 158 202
2022/20231.675 197 138 106 170 216 213 13 187 347 36 25 27
2023/2024551 44 97 23 120 46 118 7 6 6 14 10 60
2024/20252.239 130 41 197 60 66 134 183 181 96 104 297 750
2025/20264.174 678 269 300 493 515 264 504 120 607 424 0 0
Totale 13.961